SAN DIEGO (AP) _ Regulus Therapeutics Inc. (RGLS) on Thursday reported a loss of $5 million in its second quarter.
The San Diego-based company said it had a loss of 30 cents per share.
The biopharmaceutical company posted revenue of $18,000 in the period.
In the final minutes of trading on Thursday, the company's shares hit 61 cents. A year ago, they were trading at $2.92.